Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Advisorshares Pure US Cannabis ETF (NY: MSOS )

7.450 -0.350 (-4.49%)
Official Closing Price Updated: 8:00 PM EDT, Oct 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Advisorshares Pure US Cannabis ETF

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
AdvisorShares MSOS Climbs 8% As Cannabis Rescheduling Sparks Investor Interest
AdvisorShares MSOS ETF surges 8% as U.S. cannabis reform nears. Explore key investment signals and market opportunities. 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
'The Biggest Opportunities For Investors Outside AI': Optimism Reigns At Benzinga Conference Amid Talks Of Cannabis Rescheduling, Tech Advances
Cannabis leaders at the Benzinga Cannabis Capital Conference see rescheduling and banking reform as game-changers for the industry. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
EXCLUSIVE: Weed Companies Will Be Treated Like Normal Businesses Once This Tax Provision Goes Away, Experts Say
Marijuana companies would be "treated like normal businesses," If the oppressive restrictions of Section 280E of the Internal Revenue Code, which prevents cannabis businesses from deducting typical... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Investor Sentiment Softens As Institutional Confidence Wanes, Survey Shows
Investor sentiment on cannabis turns neutral as delays in rescheduling and uplisting affect the market. Florida legalization also analyzed... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Will The DEA Complete Cannabis Rescheduling? Hear From Experts The Day After Harris-Trump Debate
If cannabis is reclassified, the industry could see tax reforms, research opportunities, and the development of new regulatory frameworks. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Trump Card: How Would His Second Term Treat Cannabis?
Via Benzinga
Topics Government
Exposures Political
Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains
Trump confirmed his support for recreational cannabis in Florida. and sparked a reaction in the cannabis stock market on Monday. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Looking for the Next Big Growth Opportunity? It Might Not Be in Artificial Intelligence.
Investing in cannabis could be a calculated risk worth taking right now. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?
Stocks in the cannabis sector showed varied reactions on Wednesday, after Trump's comments on the legalization of marijuana in Florida. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Cheaper Than A Big Mac: Weed Penny Stocks Emerge As Winners Amidst Market Downturn
Amidst the market backdrop, a few cannabis penny stocks, priced lower than one of McDonald's (NYSE: MCD) classics, have shown resilience. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Congressman Blumenauer Slams DEA For Postponing Marijuana Rescheduling, Places Hope In Soon-To-Be President Harris
Congressman Earl Blumenauer, a Democrat from Oregon and co-chair of the Congressional Cannabis Caucus is disappointed the U.S. Drug Enforcement Administration (DEA) opted to delay rescheduling of... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Plummet By Up To 16% On DEA Rescheduling Delay: Could This Be The Buying Opportunity Of 2024?
The market's response was immediate and pronounced. Cannabis stocks plummeted, with MOSOS ETF dropping over 10% in early trading. 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
Key Cannabis Leaders Gather For Networking At Benzinga's Fall 2024 Conference: The Last Big Event Before The Election
Join cannabis industry leaders at Benzinga's Fall Conference in Chicago. Keynotes, networking, and legalization insights. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
New SEC Filings Reveal Major Risks In Cannabis ETFs Following Recent Volatility — But There's Still Room for Optimism
Cannabis ETFs MSOS and MSOX facing regulatory uncertainty and market downturn, with potential for rebound if federal law is amended. 
Via Benzinga
Topics Cannabis ETFs Regulatory Compliance
Exposures Cannabis Legal Regulatory
The Florida Keys: Cannabis Legalization Brings The Sunshine State Into Focus
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Bay Street Butcher: A Cannabis ETF Rebalancing Triggers Volatility
How cannabis ETF volatility impacts markets amid the MJUS rebalancing. Learn how fluctuating dynamics affect cannabis stocks. 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
The Super Bowl: Cannabis Emerges As A Political Football
Via Benzinga
Topics Cannabis
Exposures Cannabis
DEA's Call For Public Input On Cannabis Garnered 42,000 Comments: Majority Want Total Legalization Or Rescheduling
Via Benzinga
Topics Cannabis
Exposures Cannabis
Atlas Shrugged… And the Market Rallied
You’d assume the degree of uncertainty surrounding one of the most important offices in the world would ignite turmoil in the market but it hasn’t. 
Via Talk Markets
'Opaque Political Processes,' DEA Rescheduling Deadline, And Now A New Presidential Candidate, It's No Wonder Cannabis Stocks Are Over The Place
Cannabis stocks faced a mixed week with Ascend Wellness rallying on debt refinancing news, while Jushi Holdings saw a decline. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks React To Biden Announcement: Monday's Closing Market Moves
The cannabis sector witnessed significant movement today, with varied performances across key stocks and ETFs following President Joe Biden’s Sunday announcement that he will not seek re-election. 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
Did Pot Just Pivot? Cannabis Preps For Possible Presidential Run
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Surge Then Plummet On News That Biden Is Bowing Out Of 2024 Presidential Race
President Joe Biden's announcement that he will not seek re-election has impacted the cannabis stock market. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Joe Biden Drops Out: What Would Happen With Cannabis Legalization Under Kamala Harris Or Donald Trump?
With Joe Biden out of the presidential race and Kamala Harris likely in, we analyze what's next for cannabis legalization. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
This Is What a Top Cannabis Executive Thinks Is Going to Happen in the Industry in the Next 10 to 15 Years
Many cannabis companies simply can't continue on their current paths for much longer. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Zero Fees, High Hopes: WEED ETF's Strategy To Capitalize On Impending Cannabis Rescheduling
Roundhill's WEED ETF drops fees to 0%, leveraging anticipated rescheduling. Discover the impact and investment opportunities in cannabis ETFs. 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
Will Biden's Shaky Debate Performance Affect Cannabis Reform? How A Trump Return Could Reshape Marijuana Policy
President Joe Biden's shaky debate performance this week is stirring doubts among Democrats about his viability for reelection. As doubts about the president's electability circulate, questions 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
U.S. Dollar Soars: How Does This Threaten Your Cannabis Investments? Confidential Insights
In a recent issue of "Cannabis Confidential," Todd Harrison provides a succinct analysis of the current market dynamics within the cannabis industry, particularly highlighting the performance... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
7 Cannabis Stocks to Buy Now: June 2024
Cannabis may be controversial. But it’s also proving to be one of the most profitable, with some of the top cannabis stocks to buy now. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
What Is The Trump Factor? Justice Dept's Impact On Cannabis Rescheduling, Stocks And Investments
Equity research firm Zuanic & Associates convened a panel in mid-June featuring industry experts to dissect the ongoing cannabis rescheduling efforts in the US. They provided a comprehensive outlook on... 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.